IP Library Granted Patent US 7,258,967
Granted Patent B1
US 7,258,967 · App. 11/550,461 · Granted Aug 21, 2007

Photothermographic materials containing print stabilizers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,258,967
App. No.
11/550,461
Granted
Aug 21, 2007
Kind
B1
Abstract

Incorporating a sulfonyldiphenol compound into photothermographic materials improves Raw Stock Keeping and post-processing “hot-dark” print stability especially under harsh environmental conditions such as high temperature.

Claims (30)

1. A black-and-white photothermographic material comprising a support having on at least one side thereof, one or more photothermographic imaging layers comprising in reactive association:

a. a photosensitive silver halide,

b. a non-photosensitive source of reducible silver ions,

c. a reducing agent for said reducible silver ions, and

d. a polymeric binder,

said material further comprising a sulfonyldiphenol in an amount of at least 0.01 mmol/m 2 .

2. The material of claim 1 having layers coated out of organic solvents and said polymeric binder is a hydrophobic binder.

3. The material of claim 1 wherein said sulfonyldiphenol is a 4,4′-sulfonyldiphenol that is represented by the following Structure (SDP):

wherein R 1 through R 8 are independently hydrogen or halo, alkyl, alkoxy, cyano, nitro, trihaloalkyl, ester, ketone, or haloalkyl groups.

4. The material of claim 3 wherein R 1 through R 8 are independently hydrogen or bromo, chloro, methyl, or ethyl groups.

5. The material of claim 3 wherein R 1 through R 4 are independently hydrogen or bromo, chloro, methyl, or ethyl groups, and each of R 5 through R 8 is hydrogen.

6. The material of claim 1 wherein said sulfonyldiphenol is present in an amount of from about 0.05 to about 6 mmol/m 2 .

7. The material of claim 1 wherein said sulfonyldiphenol is one or more of the following Compounds SDP-1 through SDP-3:

8. The material of claim 1 further comprising a high contrast enhancing agent, co-developer, or both.

9. The material of claim 8 wherein said high contrast enhancing agent or co-developer is a substituted acrylonitrile compound, a trityl hydrazide or formyl phenyl hydrazide, substituted isoxazole, substituted malondialdehyde, cyclic enol, hydroxylamine, alkanolamine, ammonium phthalamate, hydroxamic acid, N-acylhydrazine, or hydrogen atom donor compound.

10. The material of claim 1 wherein the total amount of silver is less than 1.9 g/m 2 .

11. The material of claim 1 wherein said silver halide is present as silver bromide or silver iodobromide grains having an average grain size of from about 20 to about 60 nm.

12. The material of claim 1 further comprising a protective overcoat layer disposed over said photothermographic layer, and interlayer, carrier layer, or any combination thereof, wherein any of the protective overcoat layer, interlayer, and carrier layer includes said sulfonyldiphenol.

13. The material of claim 1 wherein said sulfonyldiphenol is present in an amount of from about 0.05 to about 2 mmol/m 2 .

14. The material of claim 1 wherein said reducing agent is a mixture of two or more hindered monophenol reducing agents, hindered bisphenol reducing agents, and hindered trisphenol reducing agents.

15. The material of claim 1 having a total silver coverage of from about 1 to about 2.6 g/m 2 .

16. The material of claim 1 wherein said sulfonyldiphenol is

17. A method of forming a visible black-and-white image comprising:

A) imagewise exposing the photothermographic material of claim 1 to electromagnetic radiation to form a latent image, and

B) simultaneously or sequentially, heating said exposed photothermographic material to develop said latent image into a visible image.

18. The method of claim 17 wherein said imagewise exposing is carried out using laser imaging at from about 600 to about 1200 nm and said development is carried out for 20 seconds or less.

19. The method of claim 17 wherein said sulfonyldiphenol is a 4,4′-sulfonyldiphenol that is present in an amount of from about 0.05 to about 6 mmol/m 2 , and is represented by the following Structure (SDP):

wherein R 1 through R 8 are independently hydrogen or halo, alkyl, alkoxy, cyano, nitro, trihaloalkyl, ester, ketone, and haloalkyl groups.

20. The method of claim 17 wherein said photothermographic material comprises a 4,4′-sulfonyldiphenol that is

and is present in an amount of from about 0.05 to about 6 mmol/m 2 .

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Oct 14, 2022
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: CARESTREAM HEALTH, INC.; CARESTREAM DENTAL, LLC; QUANTUM MEDICAL IMAGING, L.L.C.; QUANTUM MEDICAL HOLDINGS, LLC; TROPHY DENTAL INC.
Reel/Frame 061681/0380 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (FIRST LIEN) Recorded Oct 14, 2022
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: CARESTREAM HEALTH, INC.; CARESTREAM DENTAL LLC; QUANTUM MEDICAL IMAGING, L.L.C.; TROPHY DENTAL INC.
Reel/Frame 061683/0441 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (SECOND LIEN) Recorded Oct 14, 2022
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: CARESTREAM HEALTH, INC.; CARESTREAM DENTAL LLC; QUANTUM MEDICAL IMAGING, L.L.C.; TROPHY DENTAL INC.
Reel/Frame 061683/0601 →
GRANT OF SECURITY INTEREST IN PATENT RIGHTS - ABL Recorded Sep 30, 2022
From: CARESTREAM HEALTH, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 061579/0301 →
GRANT OF SECURITY INTEREST IN PATENT RIGHTS - TL Recorded Sep 30, 2022
From: CARESTREAM HEALTH, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 061579/0341 →